Skip to content

Clinical trials

Terminated Immunoglobulin Light-chain Amyloidosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Status: Terminated Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20041
20061
20071
20081
20091
20131
20152
20161
20172
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Medical Center4
Prothena Biosciences Ltd.3
Alliance for Clinical Trials in Oncology1
Barbara Ann Karmanos Cancer Institute1
City of Hope Medical Center1
Eastern Cooperative Oncology Group1
M.D. Anderson Cancer Center1
National Cancer Institute (NCI)1
Oncopeptides AB1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis17
Multiple Myeloma8
Neoplasms, Plasma Cell7
Burkitt Lymphoma5
Hodgkin Disease5
Leukemia5
Leukemia, Hairy Cell5
Leukemia, Lymphocytic, Chronic, B-Cell5
Leukemia, Myeloid, Acute5
Leukemia, Myelomonocytic, Chronic5

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.